JP2024500912A5 - - Google Patents
Info
- Publication number
- JP2024500912A5 JP2024500912A5 JP2023538150A JP2023538150A JP2024500912A5 JP 2024500912 A5 JP2024500912 A5 JP 2024500912A5 JP 2023538150 A JP2023538150 A JP 2023538150A JP 2023538150 A JP2023538150 A JP 2023538150A JP 2024500912 A5 JP2024500912 A5 JP 2024500912A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- seq
- asthma
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063128922P | 2020-12-22 | 2020-12-22 | |
| US63/128,922 | 2020-12-22 | ||
| US202163192854P | 2021-05-25 | 2021-05-25 | |
| US63/192,854 | 2021-05-25 | ||
| US202163220182P | 2021-07-09 | 2021-07-09 | |
| US63/220,182 | 2021-07-09 | ||
| US202163285513P | 2021-12-03 | 2021-12-03 | |
| US63/285,513 | 2021-12-03 | ||
| PCT/EP2021/086689 WO2022136209A1 (en) | 2020-12-22 | 2021-12-20 | Interleukin 5 binding protein dosage regimen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024500912A JP2024500912A (ja) | 2024-01-10 |
| JP2024500912A5 true JP2024500912A5 (https=) | 2024-12-18 |
Family
ID=86732980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023538150A Pending JP2024500912A (ja) | 2020-12-22 | 2021-12-20 | インターロイキン５結合タンパク質の投与レジメン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240043524A1 (https=) |
| EP (2) | EP4267184B1 (https=) |
| JP (1) | JP2024500912A (https=) |
| CA (1) | CA3199805A1 (https=) |
| ES (1) | ES3057414T3 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026078117A1 (en) * | 2024-10-11 | 2026-04-16 | Glaxosmithkline Intellectual Property Development Limited | Anti-il-5 antibody in the treatment of chronic rhinosinusitis with nasal polyps |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE042822T2 (hu) * | 2011-04-20 | 2019-07-29 | Amgen Inc | Automata befecskendezõ szerkezet |
| WO2015026737A1 (en) * | 2013-08-19 | 2015-02-26 | Dr. Reddy's Laboratories, Ltd. | Selectable single dose auto-injector and methods of making and using same |
| CN117018188A (zh) | 2017-05-26 | 2023-11-10 | 葛兰素史密斯克莱知识产权发展有限公司 | 生物制药组合物和相关方法 |
| BR112019025736A2 (pt) * | 2017-06-06 | 2020-06-30 | Glaxosmithkline Llc | uso de um anticorpo e composições para tratar uma doença e para diminuir uma contagem absoluta de eosinófilo no sangue |
| US11613571B2 (en) * | 2018-05-23 | 2023-03-28 | Glaxosmithkline Intellectual Property Development Limited | Biopharmaceutical compositions comprising antibody variants |
-
2021
- 2021-12-20 CA CA3199805A patent/CA3199805A1/en active Pending
- 2021-12-20 EP EP21844228.3A patent/EP4267184B1/en active Active
- 2021-12-20 EP EP25195590.2A patent/EP4644416A3/en active Pending
- 2021-12-20 US US18/258,588 patent/US20240043524A1/en active Pending
- 2021-12-20 ES ES21844228T patent/ES3057414T3/es active Active
- 2021-12-20 JP JP2023538150A patent/JP2024500912A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517236A5 (https=) | ||
| JP2025172841A5 (https=) | ||
| JP2017160208A5 (https=) | ||
| JP2022532927A5 (https=) | ||
| RU2017108173A (ru) | Комбинированная терапия на основе антител, активирующих человеческий cd40, и антител к человеческому pd-l1 | |
| RU2006120950A (ru) | Антитело к cd40: препарат и способы | |
| IL316404A (en) | A safe and effective method for treating psoriasis with a specific anti-IL23 antibody | |
| JP2020500152A5 (https=) | ||
| CN111787981B (zh) | 增加肌肉量和减少脂肪量的方法 | |
| JP2019534003A5 (https=) | ||
| JP2019521156A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| JP2020535149A5 (https=) | ||
| TW202310872A (zh) | 藉由投予ｐｃｓｋ９抑制劑治療糖尿病患者高血脂症之方法 | |
| JP2023542257A5 (https=) | ||
| JP2019521156A (ja) | Ｉｌ−１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2020523384A5 (https=) | ||
| JP2022536088A5 (https=) | ||
| JP2021523881A5 (https=) | ||
| JP2024542777A5 (https=) | ||
| JP2021532176A5 (https=) | ||
| JP2024500912A5 (https=) | ||
| JP2023546503A5 (https=) | ||
| JP2022514561A5 (https=) | ||
| JP2009538916A5 (https=) |